AbbVie P/E Ratio

AbbVie (4AB.DE) currently reports a P/E ratio of 83.08. That is above the Healthcare sector average of 70.94. Use the charts on this page to explore AbbVie's P/E ratio history and peer comparisons.

AbbVie's P/E ratio of 83.08 is higher than the Healthcare sector average of 70.94. That is roughly 17.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates AbbVie's market price to a fundamental measure such as earnings, sales, or book value. At 83.08, 4AB.DE can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of 83.08, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 70.94. From there, open related valuation or income-statement pages for AbbVie, and consider following 4AB.DE for alerts when major investors trade the stock.

AbbVie is classified in the Healthcare sector. On P/E ratio, it currently shows 83.08 versus a sector average near 70.94. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 4AB.DE with unrelated industries.